AI GxP validation for regulated life sciences
Whitepaper

AI-Assisted Clinical Documentation — a Buyer's Guide for CROs and Sponsors

How to evaluate AI-assisted clinical writing platforms for CSR, protocol, safety-narrative, IB, DSUR and CER work — with the eight sponsor questions and the twelve buyer criteria that separate serious tools from demo-ware.

Quick chat on WhatsAppFree to read in fullNo form to read anything
Read the checklist
clinical documentation AI whitepaperCSR AI buyer guidemedical writing AITraceDraft whitepaper
In short

Evaluating AI for clinical documentation comes down to one question that most demos avoid: can the system show, for any sentence it produced, exactly which source data it came from. Fluency is now commodity. Provenance, a usable review workflow, and a compliance posture that holds under inspection are what separate the tools.

Your shortlist criteria
Fits how you validate (CSV or CSA)Must
Part 11 and Annex 11 records and signaturesMust
Evidence you can export and keepMust
AI features you can actually validateShould
Total cost over three years, validation includedShould
Supplier evidence you can rely onNice
Weights set before demosSo the demo cannot set them for you
A fair comparison weighs the same criteria for every option, and sets the weights before the first demo. Every platform suits some teams; the shortlist is about which one suits yours.

Provenance — the question that decides it

Ask this first. A tool that cannot answer it is a drafting assistant, whatever the demo claims, and it will not survive a sponsor audit.

  • 1

    Sentence-level source linking

    Click any generated sentence and see the dataset row, listing entry or protocol clause behind it.

  • 2

    Provenance survives export

    The link persists into the delivered document or an accompanying evidence pack, not only inside the vendor's interface.

  • 3

    Unsupported statements flagged

    The system marks what it could not ground, rather than producing it with equal confidence.

  • 4

    Numbers computed, not generated

    Counts, percentages and summary statistics calculated deterministically from source data.

Apply this on a real systemSee GxP Copilot work on your own URS, or chat with us on WhatsApp.

The review workflow

Where most pilots quietly fail. If reviewing the output costs as much as writing it, the tool has moved work rather than removed it.

  • 5

    Reviewer sees source alongside draft

    Side by side, without leaving the tool to open the source dataset separately.

  • 6

    Changes tracked and attributable

    Who changed what, when, and whether the change was accepted into the final document.

  • 7

    Segregation of duties enforced

    The person approving cannot be the person who generated, enforced by the system.

  • 8

    Partial acceptance supported

    Accept some sections, send others back, without regenerating the whole document.

  • 9

    Realistic review-time estimate

    Ask the vendor for measured review time on a document like yours, not generation time.

Compliance posture

  • 10

    Real 21 CFR Part 11 signatures

    Re-authentication at signing, signature meaning, permanent linking, frozen signed versions. Not a checkbox labelled approve.

  • 11

    Tamper-evident audit trail

    Covers generation, edit, review and approval, and cannot be disabled by any production role.

  • 12

    Validation documentation available

    The vendor can supply validation evidence for their own platform, and a validation pack you can execute.

  • 13

    Annex 22 alignment

    Model governance, evaluation set, human oversight, drift monitoring and a documented fallback.

Data, model and commercial terms

  • 14

    Data residency and processing location

    Where clinical data is processed and stored, and under which jurisdiction.

  • 15

    No training on your data

    Contractually explicit, not a settings toggle that a future release could change.

  • 16

    Model portability

    Whether the underlying model can be changed, and whether you can pin a version.

  • 17

    Change notification

    The vendor must tell you before the model changes, or your validated state is not yours to control.

  • 18

    Exit and data extraction

    You can leave with your documents, their provenance and the audit trail intact.

How to run the evaluation

Vendor demos use vendor data. The only evaluation worth anything uses yours.

  • 19

    Bring your own study

    A real, awkward, representative document — not the clean example the vendor suggests.

  • 20

    Include a known-messy input

    Missing values, late protocol amendment, a dataset that does not quite match the spec.

  • 21

    Measure total time to approved

    Generation plus review plus rework, compared against your current baseline for the same document.

  • 22

    Have a medical writer judge quality

    Not the project sponsor. The person who would have written it is the only credible assessor.

How to use this

Generation quality has converged across serious vendors. Choosing on output fluency alone is choosing on the dimension that differentiates least.

The honest benchmark is total time from inputs to an approved document, against your current baseline for the same kind of document. Generation speed on its own tells you almost nothing.

This is a working aid, not a regulatory document, and it does not replace your own quality system procedures.

Explore related resources, products and services: GxP Copilot, TraceDraft, validation services, AI transformation.

clinical documentation AI whitepaperCSR AI buyer guidemedical writing AITraceDraft whitepaper

Sources

Primary documents referred to on this page, from their official publishers.

FAQ

Common questions

Prefer to talk first? Chat with us on WhatsApp or book a call with an expert.

What should we look for in AI clinical documentation software?

Sentence-level provenance back to source data that survives export; a review workflow that shows source alongside draft; real 21 CFR Part 11 signatures with re-authentication and record freezing; a tamper-evident audit trail; contractual guarantees on data residency and model-change notification; and a clean exit path for your documents and their audit trail.

How do we evaluate AI medical writing tools fairly?

Use your own study, including a deliberately messy one with missing values or a late amendment. Measure total time from inputs to approved document — generation plus review plus rework — against your current baseline. Have the medical writer who would otherwise have written it judge the quality, not the project sponsor.

Why does provenance matter more than writing quality?

Because fluency has converged across serious vendors while traceability has not. A sponsor or inspector asking where a particular statement came from needs an answer that points at a dataset row. Without that, every sentence has to be verified manually, which removes most of the time saving the tool was bought for.

Can AI-generated clinical documents be used in a regulatory submission?

Yes, where a qualified human has reviewed and approved them and the usual record requirements are met. The AI is an authoring aid; accountability stays with the named author and approver. What matters to a regulator is that the content is accurate, traceable to source, and approved under a compliant signature.

Put this to work on your system.

Bring a URS. We show you risk-sized testing on your own requirements.

  • We reply within one business day
  • We run your URS live on the call
  • You get a clear plan for your system
Chat on WhatsApp

Book a demo

Four fields. The right specialist replies within one business day.

Your details stay private. We never share them.